PIEKOS BRIAN (Chief Financial Officer) sold 9.3% of their position (1.86K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $37.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/20/2026ACC: 0001815308-26-000003
Officer· Chief Financial Officer
Since Feb 2026
-1.86K
Net shares
Net seller
$37.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.25K acquired · 8.11K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.25K
Price / share
—
Trade value
—
% of position
45.4%
4/16/2026
13.76K→20.01K
Common Stock
Direct
Shares
−1.86K
Price / share
$20.22
Trade value
$37.64K
% of position
9.3%
4/17/2026
20.01K→18.15K
Total
Net shares
+4.39K
Net value
-$37.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/16/2026 | M · Option Exercise | +6.25K | — | — | 45.4% | 13.76K | 20.01K |
| Common Stock Direct | 4/17/2026 | S · Sale | −1.86K | $20.22 | $37.64K | 9.3% | 20.01K | 18.15K |
| Total | +4.39K | -$37.64K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
6.25K shares
Shares
−6.25K
Strike price
Held after
93.75K
Exercisable
—
4/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock6.25K shares | 4/16/2026 | M · Option Exercise | −6.25K | — | 93.75K |